Marine-derived n-3 fatty acids therapy for stroke

Celia Gabriela Alvarez Campano; Mary Joan Macleod; Frank Thies; Lorna Aucott; Malcolm R. Macleod

doi:10.1002/14651858.CD012815

Marine-derived n-3 fatty acids therapy for stroke

Celia Gabriela Alvarez Campano^*, Mary Joan Macleod, Frank Thies, Lorna Aucott, Malcolm R. Macleod

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

7 Downloads (Pure)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of marine-derived n-3 fatty acids administration on functional outcomes and dependence in people with stroke.

Original language	English
Article number	CD012815
Pages (from-to)	1-12
Number of pages	12
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD012815
Publication status	Published - 10 Oct 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/14651858.CD012815Licence: Unspecified

Marine-derived n-3 fatty acids therapy for stroke (Protocol)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Final published version, 224 KBLicence: Other

Cite this

@article{731be65cf3fc489c8829249a2ea0d629,

title = "Marine-derived n-3 fatty acids therapy for stroke",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of marine-derived n-3 fatty acids administration on functional outcomes and dependence in people with stroke.",

author = "{Alvarez Campano}, {Celia Gabriela} and Macleod, {Mary Joan} and Frank Thies and Lorna Aucott and Macleod, {Malcolm R.}",

note = "We thank the Cochrane Stroke Group, and in particular Hazel Fraser (Managing Editor) and Joshua Cheyne (Trials Search Coordinator and Information Specialist), for their support in the development of this protocol. CG Alvarez Campano is funded by the Mexican Council for Science and Technology (CONACyT) and the Institute of Innovation and Technology Transfer (I²T²) (grant number 457349).",

year = "2017",

month = oct,

day = "10",

doi = "10.1002/14651858.CD012815",

language = "English",

volume = "2017",

pages = "1--12",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Wiley",

number = "10",

}

TY - JOUR

T1 - Marine-derived n-3 fatty acids therapy for stroke

AU - Alvarez Campano, Celia Gabriela

AU - Macleod, Mary Joan

AU - Thies, Frank

AU - Aucott, Lorna

AU - Macleod, Malcolm R.

N1 - We thank the Cochrane Stroke Group, and in particular Hazel Fraser (Managing Editor) and Joshua Cheyne (Trials Search Coordinator and Information Specialist), for their support in the development of this protocol. CG Alvarez Campano is funded by the Mexican Council for Science and Technology (CONACyT) and the Institute of Innovation and Technology Transfer (I²T²) (grant number 457349).

PY - 2017/10/10

Y1 - 2017/10/10

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of marine-derived n-3 fatty acids administration on functional outcomes and dependence in people with stroke.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of marine-derived n-3 fatty acids administration on functional outcomes and dependence in people with stroke.

UR - http://www.scopus.com/inward/record.url?scp=85030847409&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012815

DO - 10.1002/14651858.CD012815

M3 - Article

AN - SCOPUS:85030847409

VL - 2017

SP - 1

EP - 12

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 10

M1 - CD012815

ER -

Marine-derived n-3 fatty acids therapy for stroke

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this